Your provider can explain trade-offs based on your goals and medical history
doi: 10.1080/21641846.2022.2124775 Summary Keywords myalgic encephalomyelitis/chronic fatigue syndrome, pathology, treatment, pathophysiology, diagnostic criteria Citation Arron HE, Marsh BD, Kell DB, Khan MA, Jaeger BR and Pretorius E (2024) Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease
Frontiers in Pharmacology, 12 , 627533
The peptide just won't dissolve
Neuropeptides, by contrast, are explicitly designed to cross the blood-brain barrier and modulate neurotransmitter systems
Understanding the specific effects reported helps set realistic expectations and allows for informed monitoring during treatment protocols